Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain

NCT ID: NCT00076544

Last Updated: 2015-12-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this open-label study is to give chronic severe pain patients with existing intrathecal pump systems access to ziconotide.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Intrathecal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ziconotide

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Each patient must have chronic severe pain of malignant or nonmalignant etiology with inadequate pain relief from or intolerance to conventional therapy.
* Each patient must have a predicted life expectancy of greater than or equal to 6 weeks relative to baseline.
* Each patient must be able to respond to the Visual Analog Scale of Pain Intensity (VASPI).
* Each patient must have an implanted programmable SynchroMed infusion device or a CADD-Micro external programmable infusion device and spinal catheter (hereafter "IT pump and spinal catheter") prior to enrollment into this trial. (If a patient has an external pump, the Investigator must ensure that the patient is at a low risk for infection and that the patient is capable of maintaining good personal hygiene. The Investigator must have demonstrated the ability to successfully manage patients with external pumps prior to enrolling a patient in this trial.)
* Each patient must be at least 18 years of age.
* Each patient must be competent to give written informed consent and has given written informed consent prior to performance of any study-related procedures. Reasonable accommodation of visually impaired patients will be allowed.
* Each patient is willing and able to comply with the protocol requirements.
* Each female patient of childbearing potential must agree to use adequate contraceptive methods while on PRIALT as determined by the Investigator.

Exclusion Criteria

* Presence of pregnancy or lactation.
* Participation in another investigational drug or device trial within the preceding 30 days.
* Presence of known hypersensitivity to PRIALT or any of its components.
* Presence of any contraindication to continued IT therapy (for example, infection at the pump or catheter externalization site, uncontrolled bleeding diathesis, spinal canal obstruction that impairs cerebrospinal fluid \[CSF\] circulation, or patient and caregiver inability to manage and protect the IT pump and spinal catheter system and return for clinic follow up visits).
* Presence of any condition (for example, psychosis, severe depression or suicidal ideation, homicidality, somatization disorder, active substance abuse, cognitive deficits, dementia or other serious medical or psychiatric condition) that in the Investigator's opinion precludes the patient's ability to participate in this study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Elan Pharmaceuticals

INDUSTRY

Sponsor Role lead

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Alabama Pain Center

Huntsville, Alabama, United States

Site Status

Center for Pain Management

Huntsville, Alabama, United States

Site Status

Otto Uhrik, MD

Sun City West, Arizona, United States

Site Status

Outcomes Research International

Tucson, Arizona, United States

Site Status

The RC Goodman Pain Institute

Fort Smith, Arkansas, United States

Site Status

Innovative Spine Care

Little Rock, Arkansas, United States

Site Status

Shreenath Clinical Services

Beverly Hills, California, United States

Site Status

Advanced Pain Institute

Duarte, California, United States

Site Status

Shreenath Clinical Services

Lake Forest, California, United States

Site Status

Shreenath Clinical Services

Long Beach, California, United States

Site Status

Bay Area Pain Center

Los Gatos, California, United States

Site Status

Northridge Surgery & Pain Management Center

Northridge, California, United States

Site Status

Pacific Pain Medicine Consultants

Oceanside, California, United States

Site Status

Pacific Pain Treatment Centers

San Francisco, California, United States

Site Status

Galileo Surgery Center

San Luis Obispo, California, United States

Site Status

Pain Relief Center of Colorado

Arvada, Colorado, United States

Site Status

Pain Care Specialists

Colorado Springs, Colorado, United States

Site Status

Rocky Mountain Clinical Research

Golden, Colorado, United States

Site Status

Comprehensive Pain and Headache Treatment Centers, LLC

Derby, Connecticut, United States

Site Status

Florida Institute of Medical Research

Jacksonville, Florida, United States

Site Status

Space Coast Pain Institute

Merritt Island, Florida, United States

Site Status

West Gables Rehabilitation Hospital

Miami, Florida, United States

Site Status

Sarasota Pain Associates

Sarasota, Florida, United States

Site Status

Clinical Pharmacology Services

Tampa, Florida, United States

Site Status

Shepherd Center, Inc.

Atlanta, Georgia, United States

Site Status

Comprehensive Pain Care, PC

Marietta, Georgia, United States

Site Status

The University of Chicago, Dept. of Surgery, Section of Neurosurgery

Chicago, Illinois, United States

Site Status

Indianapolis Neurosurgical Group

Indianapolis, Indiana, United States

Site Status

University of Iowa Health Care

Iowa City, Iowa, United States

Site Status

Des Moines Orthopedic Surgeons

West Des Moines, Iowa, United States

Site Status

University of Kentucky

Lexington, Kentucky, United States

Site Status

Pain Control Network, PSC/PCN Surgical Suites, LLC

Louisville, Kentucky, United States

Site Status

Wayne State University - School of Medicine

Detroit, Michigan, United States

Site Status

Medical Advanced Pain Specialists (MAPS)

Minneapolis, Minnesota, United States

Site Status

The Center for Pain Medicine

Hattiesburg, Mississippi, United States

Site Status

Pain Management Associates, Clinical Research

Independence, Missouri, United States

Site Status

St. John's Regional Healthcare

Springfield, Missouri, United States

Site Status

Pain Management - Anesthesiology

Las Vegas, Nevada, United States

Site Status

Dr. O'Connell's Pain Care Centers, Inc.

Somersworth, New Hampshire, United States

Site Status

All Island Pain Consultants

Bay Shore, New York, United States

Site Status

Cohn Pain Management Center

Bethpage, New York, United States

Site Status

Roswell Park Cancer Institute

Buffalo, New York, United States

Site Status

NYU Pain Management Center

New York, New York, United States

Site Status

New York Presbyterian Hospital/Cornell Medical Center

New York, New York, United States

Site Status

Medical Pain Management of Central New York

Syracuse, New York, United States

Site Status

Duke Medical Center Pain Clinic

Durham, North Carolina, United States

Site Status

The Center for Clinical Research

Winston-Salem, North Carolina, United States

Site Status

Cincinnati Centers for Pain Relief, Inc.

Hamilton, Ohio, United States

Site Status

PETC Research Group, Inc.

Tulsa, Oklahoma, United States

Site Status

Pain Consultants of Oregon

Eugene, Oregon, United States

Site Status

Pain Management Consultants, PC

Portland, Oregon, United States

Site Status

Lehigh Valley Hospital

Allentown, Pennsylvania, United States

Site Status

Magee Rehabilitation

Philadelphia, Pennsylvania, United States

Site Status

Carolinas Center for Advanced Management of Pain

Spartanburg, South Carolina, United States

Site Status

Avera St. Luke's Hospital

Aberdeen, South Dakota, United States

Site Status

Dallas Spine Care P.A.

Dallas, Texas, United States

Site Status

Advanced Pain Medicine

Dallas, Texas, United States

Site Status

The University of Texas Medical Branch

Galveston, Texas, United States

Site Status

International Pain Institute

Lubbock, Texas, United States

Site Status

American Pain & Wellness, PA

Plano, Texas, United States

Site Status

Consultants in Pain Research, PA

San Antonio, Texas, United States

Site Status

Lifetree Clinical Research

Salt Lake City, Utah, United States

Site Status

University of Utah Pain Management Center

Salt Lake City, Utah, United States

Site Status

Pain Management Center, University of Virginia

Charlottesville, Virginia, United States

Site Status

The Center for Pain Relief

Charleston, West Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ELN92045-501

Identifier Type: -

Identifier Source: org_study_id